Search Results - "Pickar, James H"
-
1
Independent conclusions?
Published in Climacteric : the journal of the International Menopause Society (01-04-2023)Get full text
Journal Article -
2
Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
Published in Atherosclerosis (01-11-2016)“…Abstract In the late 1980s, several observational studies and meta-analyses suggested that hormone replacement therapy (HRT) was beneficial for prevention of…”
Get full text
Journal Article -
3
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy
Published in Fertility and sterility (01-09-2009)“…Objective To evaluate the endometrial safety of a tissue selective estrogen complex (TSEC; pairing of a selective estrogen receptor modulator [SERM] with…”
Get full text
Journal Article -
4
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women
Published in Fertility and sterility (01-09-2009)“…Objective To evaluate the efficacy of the tissue-selective estrogen complex, bazedoxifene/conjugated estrogens (BZA/CE), for postmenopausal osteoporosis…”
Get full text
Journal Article -
5
Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile
Published in Fertility and sterility (01-09-2009)“…Objective To evaluate the effects of a tissue-selective estrogen complex (TSEC) composed of bazedoxifene/conjugated estrogens (BZA/CE) on menopausal symptoms,…”
Get full text
Journal Article -
6
Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women
Published in Fertility and sterility (01-09-2009)“…Objective To evaluate the effect of bazedoxifene/conjugated estrogens (BZA/CE), a tissue selective estrogen complex, on uterine bleeding in postmenopausal…”
Get full text
Journal Article -
7
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause
Published in American journal of obstetrics and gynecology (01-02-2009)“…Objective The objective of the study was to assess the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) for menopausal…”
Get full text
Journal Article -
8
Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety
Published in American journal of obstetrics and gynecology (01-03-2009)“…Objective The objective of the study was to assess the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) for the treatment of…”
Get full text
Journal Article -
9
Tissue selective estrogen complex (TSEC): a review
Published in Menopause (New York, N.Y.) (01-09-2018)“…OBJECTIVE:This review describes historical development of selective estrogen receptor modulators (SERMs) and their combination with estrogens, termed a tissue…”
Get full text
Journal Article -
10
Selective estrogen receptor modulators (SERMs): A review of clinical data
Published in Maturitas (01-01-2015)“…Abstract SERMs represent a diverse group of molecules with varying levels of estrogenic agonist and antagonist activity in target tissues. SERMs have a long…”
Get full text
Journal Article -
11
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women
Published in Obstetrics and gynecology (New York. 1953) (01-06-2005)“…To assess the endometrial effects of bazedoxifene acetate in healthy postmenopausal women. The endometrial effects of bazedoxifene 2.5, 5.0, 10, 20, 30, and 40…”
Get full text
Journal Article -
12
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
Published in Therapeutics and clinical risk management (01-01-2016)“…Menopausal symptoms (eg, hot flushes and vaginal symptoms) are common, often bothersome, and can adversely impact women's sexual functioning, relationships,…”
Get full text
Journal Article -
13
Progesterone
Published in Climacteric : the journal of the International Menopause Society (01-08-2018)Get full text
Journal Article -
14
Conflicts of interest and the ICMJE disclosure form
Published in Climacteric : the journal of the International Menopause Society (04-05-2019)Get full text
Journal Article -
15
Publishing in Climacteric
Published in Climacteric : the journal of the International Menopause Society (04-03-2019)Get full text
Journal Article -
16
Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression
Published in Cancer biology & therapy (15-11-2009)“…Identification of biomarkers potentially provides prognostic information that can help guide clinical decision-making. Given the relationship between estrogen…”
Get full text
Journal Article -
17
Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women’s Health, Osteoporosis, Progestin, Estrogen (HOPE) trial
Published in American journal of obstetrics and gynecology (01-08-2007)“…Objective The objective of the study was to determine the effects of several doses of conjugated estrogens (CE) and CE plus medroxyprogesterone acetate (MPA)…”
Get full text
Journal Article -
18
SERMs: Progress and future perspectives
Published in Maturitas (01-10-2010)“…Abstract Selective estrogen receptor modulators (SERMs) interact with estrogen receptors as agonists or antagonists depending on the target tissue. Currently…”
Get full text
Journal Article -
19
The response to ospemifene in normal human breast tissue cultures
Published in Menopause (New York, N.Y.) (01-07-2016)Get full text
Journal Article -
20
The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy
Published in Menopause (New York, N.Y.) (01-04-2017)“…OBJECTIVE:To evaluate the safety and efficacy of TX-004HR vaginal estradiol soft-gel capsules for moderate-to-severe dyspareunia associated with postmenopausal…”
Get full text
Journal Article